Skip to main content
Premium Trial:

Request an Annual Quote

Curetis Inks European Distribution Deals for MDx Products

NEW YORK — German molecular diagnostics firm Curetis said today that it has struck two distribution deals for its Unyvero A50 instrument system and test cartridges with Ako Med.

Under the terms of the deals, Ako Med's Bosnian and Serbian branches will have the exclusive commercialization rights to the PCR-based diagnostic system and related assays in Serbia, North Macedonia, Bosnia and Herzegovina, and Montenegro. The deals have an initial term of three years and include undisclosed minimum purchases of Unyvero instruments and test cartridges by Ako Med. The deals may be extended in two-year increments.

"We are very pleased to work with Ako Med as a highly committed partner to make Unyvero more broadly available in the [Central and Eastern European] region," Curetis CEO Oliver Schacht said in a statement. "We are also working with our strategic pan-European partner Menarini Diagnostics to broaden the scope of our commercial partnership in other parts of Europe and expect to give an update on such expansion shortly."

Earlier this year, Curetis formed a long-term distribution partnership with Florence, Italy-based Menarini covering Germany, France, Belgium, the Netherlands, Luxembourg, the UK, Switzerland, Italy, Spain, Portugal, and Sweden.  

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.